Physician profile
Robin A Wright
NPI 1275978868
$1,336.33
in general payments reported to CMS, 2019-2025
24 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,190 · 2020: $146.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $179.73 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $177.33 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $146.45 | 2019 | |
| Lilly USA, LLC | $127.48 | 2019-2020 | |
| Abbvie INC. | $98.67 | 2019 | |
| Novo Nordisk INC | $95.88 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $93.13 | 2019-2020 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $79.68 | 2019 | |
| Glaxosmithkline, LLC. | $43.28 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $39.26 | 2019 | |
| Pfizer INC. | $37.75 | 2019 | |
| Ironwood Pharmaceuticals, INC | $31.90 | 2019-2020 | |
| Sanofi-Aventis U.S. LLC | $30.70 | 2019 | |
| Ucb, INC. | $19.75 | 2019 | |
| Sobi, INC | $17.58 | 2019 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $15.88 | 2020 | |
| Ultragenyx Pharmaceutical INC. | $15.80 | 2019 | |
| Astellas Pharma US INC | $15.06 | 2019 | |
| Sanofi Pasteur INC. | $13.47 | 2019 | |
| Scilex Pharmaceuticals INC. | $12.69 | 2019 | |
| Allergan, INC. | $11.80 | 2019 | |
| Zyla Life Sciences, INC. | $11.30 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $10.93 | 2019 | |
| Horizon Therapeutics Plc | $10.83 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robin Wright listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.